Biotron Limited
BITRF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.2% | 14.9% | -8.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 97.5% | 97% | 97.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18.4% | -213% | -251.6% | -175.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -17.6% | -208.9% | -244% | -178.4% |
| EPS Diluted | -0 | -0.004 | -0.004 | -0.004 |
| % Growth | 92.1% | 11.6% | -13.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |